AI assistant
Fulgent Genetics, Inc. — Director's Dealing 2020
Feb 13, 2020
32553_dirs_2020-02-12_85dda575-931e-4e5d-a736-980387961729.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: Fulgent Genetics, Inc. (FLGT)
CIK: 0001674930
Period of Report: 2019-12-31
Reporting Person: Hsieh Ming (Director, President and CEO, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-10-23 | Issuer Common Stock | J | 1315789 | $0.00 | Acquired | 7895115 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Issuer Common Stock | 0 | Indirect |
| Issuer Common Stock | 1000 | Indirect |
| Issuer Common Stock | 1000 | Indirect |
Footnotes
F1: On October 23, 2019, the Reporting Person transferred 1,315,789 shares of Common Stock of the Issuer held by the Ming Hsieh Annuity Trust established May 4, 2016, over which the reporting person possesses sole voting and dispositive power as the sole trustee, to himself as an individual.
F2: On November 30, 2017, the Reporting Person, acting as the custodian for his minor child under a Uniform Transfers to Minors Act ("UTMA") account, purchased 1,000 shares of the Issuer's Common Stock in an open market transaction at a weighted average price of $3.6042 per share.
F3: On November 30, 2017, the Reporting Person, acting as the custodian for his minor child under a UTMA account, purchased 1,000 shares of the Issuer's Common Stock in an open market transaction at a weighted average price of $3.6042 per share.